8-K
filed June 1, 2026, 12:43 PM ET
ticker TRLC
CIK 0001550453
other material
confidence high
sentiment neutral
materiality 0.40
TriLinc Global Impact Fund portfolio assets ~$283M as of April 30, 2026
TriLinc Global Impact Fund LLC
- Weighted average loan size ~$10M; weighted average duration 0.4 years.
- Aggregate investments funded ~$1.210B to 103 borrower companies globally.
- Investments support 43,572 permanent employees; $104.7M in temporary investments.
- Received ~$905.2M in full transaction repayments (75% of total invested).
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001437749-26-018969
- form_type
- 8-K
- ticker
- TRLC
- cik
- 0001550453
- company_name
- TriLinc Global Impact Fund LLC
- filed_at
- 2026-06-01T16:43:41+00:00
- discovered_at
- 2026-06-01T16:45:00.328439+00:00
- generated_at
- 2026-06-01T16:45:13.775363+00:00
- sec_items
- ["8.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.4
- calibrated_materiality_score
- 0.4
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001437749-26-018969
- json_url
- https://secwatch.observer/filing/0001437749-26-018969.json
- markdown_url
- https://secwatch.observer/filing/0001437749-26-018969.md
- text_url
- https://secwatch.observer/filing/0001437749-26-018969.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1550453/000143774926018969/0001437749-26-018969-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1550453/000143774926018969/trlc20260513_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
ONCY
Oncolytics reports positive initial preclinical data for pelareorep + RAS inhibitors; further studies planned
ONCOLYTICS BIOTECH INC
June 1, 2026, 9:06 AM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
SILO
Silo Pharma announces 1-for-15 reverse stock split effective June 2, 2026
Silo Pharma, Inc.
June 1, 2026, 9:02 AM ET
other_material
Items 8.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
NWSA
News Corp repurchased $2.75M in shares on May 29; $276.9M used under $1B program
NEWS CORP
June 1, 2026, 6:32 AM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
RDAC
Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed
Rising Dragon Acquisition Corp.
June 1, 2026, 6:08 AM ET
other_material
Items 1.01, 5.03, 5.07, 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
PSA
Public Storage reports operating update: same-store occupancy 92.2%, churn improves to 16.4%
Public Storage
June 1, 2026, 6:01 AM ET
other_material
Items 7.01, 8.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
OZ
Belpointe PREP reports Q1 2026 NAV of $453.2M, or $116.25 per Class A unit
Belpointe PREP, LLC
May 29, 2026, 6:54 PM ET
other_material
Items 8.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
APUR
Aperture AC closes IPO of 10.2M units at $10/unit, raises $102M; trust funded with $102.255M
Aperture AC
May 29, 2026, 4:15 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
OHAC
Oceanhawk Acquisition Corp closes SPAC IPO; raises $184M, trust funded with $184.92M
Oceanhawk Acquisition Corp.
May 29, 2026, 4:00 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.